Chad Mirkin discusses "Opening the Field of Digital Medicine through SNAs" at 2019 IIN Symposium

Chad A. Mirkin is the Director of the International Institute for Nanotechnology and the George B.
Rathmann Professor of Chemistry, Chemical and Biological Engineering, Biomedical Engineering, Materials Science & Engineering, and Medicine at Northwestern University. He is a chemist and a world-renowned nanoscience expert who is known for his discovery and development of spherical nucleic acids (SNAs) and SNA-based biodetection and therapeutic schemes, Dip-Pen Nanolithography (DPN) and related cantilever-free nanopatterning methodologies, On-Wire Lithography (OWL), and Co-Axial Lithography (COAL), and contributions to supramolecular chemistry and nanoparticle synthesis. Professor Mirkin received his B.S. degree from Dickinson
College (1986) and a Ph.D. degree from Penn State University (1989). He was an NSF Postdoctoral. Fellow at MIT prior to becoming a professor at Northwestern University in 1991. He has authored over 750 manuscripts and over 1,200 patent applications worldwide (over 330 issued) and founded multiple companies, including AuraSense, Exicure, TERA-print, and Azul 3D. Mirkin has been recognized with over 130 international awards, including the Perkin Medal, Wilhelm Exner Medal, the RUSNANOPRIZE, the Dan David Prize, and the Sackler Prize in Convergence Research. He served on the President’s Council of Advisors on Science & Technology (Obama Administration), and he is one of very
few scientists to be elected to all three US National Academies. Most recently he was awarded the 2019 Kabiller Prize in Nanoscience and Nanomedicine.